|
1
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Normanno N, Cervantes A, Ciardiello F, De
Luca A and Pinto C: The liquid biopsy in the management of
colorectal cancer patients: Current applications and future
scenarios. Cancer Treat Rev. 70:1–8. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Norcic G: Liquid biopsy in colorectal
cancer-current status and potential clinical applications.
Micromachines (Basel). 9(pii): E3002018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chu HY, Lu LS, Cho W, Wu SY, Chang YC, Lin
CP, Yang CY, Lin CH, Jiang JK and Tseng FG: Enumerating circulating
tumor cells with a Self-assembled cell array (SACA) Chip: A
feasibility study in patients with colorectal cancer. Cancers
(Basel). 11(pii): E562019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ashworth TR: A case of cancer in which
cells similar to those in the tumours were seen in the blood after
death. Australian Med J. 14:146–147. 1869.
|
|
7
|
Wei RR, Sun DN, Yang H, Yan J, Zhang X,
Zheng XL, Fu XH, Geng MY, Huang X and Ding J: CTC clusters induced
by heparanase enhance breast cancer metastasis. Acta Pharmacol Sin.
39:1326–1337. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Klameth L, Rath B, Hochmaier M, Moser D,
Redl M, Mungenast F, Gelles K, Ulsperger E, Zeillinger R and
Hamilton G: Small cell lung cancer: Model of circulating tumor cell
tumorospheres in chemoresistance. Sci Rep. 7:53372017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee AW, Lin FX, Wei PL, Jian-Wei G and
Chen JK: Binary-blend fibber-based capture assay of circulating
tumor cells for clinical diagnosis of colorectal cancer. J
Nanobiotechnology. 16:42018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chou WC, Wu MH, Chang PH, Hsu HC, Chang
GJ, Huang WK, Wu CE and Hsieh JC: A prognostic model based on
circulating tumour cells is useful for identifying the poorest
survival outcome in patients with metastatic colorectal cancer. Int
J Biol Sci. 14:137–146. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang C, Shi D, Wang S, Wei C, Zhang C and
Xiong B: Prognostic value of pre- and post-operative circulating
tumor cells detection in colorectal cancer patients treated with
curative resection: A prospective cohort study based on ISET
device. Cancer Manag Res. 10:4135–4144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu F, Zhu J, Mao Y, Li X, Hu B and Zhang
D: Associations between the Epithelial-mesenchymal transition
phenotypes of circulating tumor cells and the clinicopathological
features of patients with colorectal cancer. Dis Markers.
2017:94745322017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang W, Wan L, Wu S, Yang J, Zhou Y, Liu
F, Wu Z and Cheng Y: Mesenchymal marker and LGR5 expression levels
in circulating tumor cells correlate with colorectal cancer
prognosis. Cell Oncol (Dordr). 41:495–504. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai J, Huang L, Huang J, Kang L, Lin H,
Huang P, Zhu P, Wang J, Dong J, Wang L and Xian CJ: Associations
between the cyclooxygenase-2 expression in circulating tumor cells
and the clinicopathological features of patients with colorectal
cancer. J Cell Biochem. 120:4935–4941. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Andree KC, van Dalum G and Terstappen LW:
Challenges in circulating tumor cell detection by the CellSearch
system. Mol Oncol. 10:395–407. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sheng Y, Wang T, Li H, Zhang Z, Chen J, He
C, Li Y, Lv Y, Zhang J, Xu C, et al: Comparison of analytic
performances of Cellsearch and iFISH approach in detecting
circulating tumor cells. Oncotarget. 8:8801–8806. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye Z, Ding Y, Chen Z, Li Z, Ma S, Xu Z,
Cheng L, Wang X, Zhang X, Ding N, et al: Detecting and phenotyping
of aneuploid circulating tumor cells in patients with various
malignancies. Cancer Biol Ther. 20:546–551. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu W, Zhang Z, Gao XH, Shen Z, Jing Y, Lu
H, Li H, Yang X, Cui X, Li Y, et al: Clinical significance of
detecting circulating tumor cells in colorectal cancer using
subtraction enrichment and immunostaining-fluorescence in situ
hybridization (SE-iFISH). Oncotarget. 8:21639–21649.
2017.PubMed/NCBI
|
|
19
|
O'Sullivan B, Brierley J, Byrd D, Bosman
F, Kehoe S, Kossary C, Piñeros M, Van Eycken E, Weir HK and
Gospodarowicz M: The TNM classification of malignant
tumours-towards common understanding and reasonable expectations.
Lancet Oncol. 18:849–851. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chistiakov DA and Chekhonin VP:
Circulating tumor cells and their advances to promote cancer
metastasis and relapse, with focus on glioblastoma multiforme. Exp
Mol Pathol. 105:166–174. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou L, Dicker DT, Matthew E, El-Deiry WS
and Alpaugh RK: Circulating tumor cells: Silent predictors of
metastasis. F1000Res. 6(pii): F1000Faculty Rev. –1445.
2017.PubMed/NCBI
|
|
22
|
Stanesby O and Jenkins M: Comparison of
the efficiency of colorectal cancer screening programs based on age
and genetic risk for reduction of colorectal cancer mortality. Eur
J Hum Genet. 25:832–838. 2017. View Article : Google Scholar : PubMed/NCBI
|
